Showing results (121-130 of 570) with videos related to

Sort By:
Pageof 57
Frontiers in Oncology|April 27, 2019
Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent PembrolizumabBrooke C Bloom, Alexander Augustyn, Todd A Pezzi, et al.
Frontiers in Oncology|September 9, 2021
Pulsed Radiation Therapy to Improve Systemic Control of Metastatic CancerKewen He, Hampartsoum B Barsoumian, Duygu Sezen, et al.
Frontiers in Immunology|November 12, 2020
Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic ApproachesKatherine Klein, Kewen He, Ahmed I Younes, et al.
Cancer Immunology Research|April 18, 2020
SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti-PD-1-Resistant Model of Non-Small Cell Lung CancerDawei Chen, Hampartsoum B Barsoumian, Liangpeng Yang, et al.
Frontiers in Oncology|August 28, 2020
Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal CarcinomaSteven N Seyedin, Margaret K Gannon, Kristin A Plichta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 5, 2013
Aortic dose constraints when reirradiating thoracic tumorsJaden D Evans, Daniel R Gomez, Arya Amini, et al.
Frontiers in Immunology|October 24, 2022
Pulsed radiotherapy to mitigate high tumor burden and generate immune memoryDuygu Sezen, Hampartsoum B Barsoumian, Kewen He, et al.
Immunotherapy|February 10, 2018
Radiation therapy and immunotherapy: what is the optimal timing or sequencing?Maureen L Aliru, Jonathan E Schoenhals, Bhanu P Venkatesulu, et al.
Oncotarget|July 11, 2018
Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical trials with VEGF/VEGFR inhibitorsIshwaria M Subbiah, Chad Tang, Arvind Rao, et al.
Physics and Imaging in Radiation Oncology|January 16, 2026
Dosimetric effect of abdominal compression in online adaptive planning for abdominal cancers treated with a 1.5 Tesla magnetic resonance-guided linear acceleratorMoghadaseh Khaleghibizaki, Angela Sobremonte, Luis Perles, et al.
Pageof 57